Accuray Incorporated (ARAY) Dividend History

Accuray Incorporated is a medical device company that develops, manufactures, and sells radiation therapy systems for cancer treatment. Known for its CyberKnife and TomoTherapy products, the company focuses on providing precise, minimally invasive radiation solutions to improve patient outcomes.

1240 Deming Way, Madison, WI, 53717
Phone: 608-824-2800
Website: https://www.accuray.com

Dividend History

Accuray Incorporated currently does not pay dividends

Company News

  • The medical robots market is projected to reach $34.32 billion by 2031, growing at a CAGR of 17.4% during the forecast period. The rising demand for minimally invasive surgeries, particularly among the aging population, is driving the market growth. Surgical robots are the largest segment, offering advantages like reduced scarring, faster recovery, and enhanced precision for surgeons.

    GlobeNewswire Inc.
    Featured Companies: ISRG MDT SYK
  • Accuray (ARAY) announces an agreement with TrueNorth to provide radiation oncology departments with third-party support designed to improve their department's capabilities.

    Zacks Investment Research
    Featured Companies: BSX DVA ECL
  • Accuray faces tough competition from Varian and Elekta, but is focusing on upgrading its installed base. Read why ARAY stock is a Buy.

    Seeking Alpha
  • Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2 million and $0.7 million respectively. Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares climbed 73.6% to $0.3230 after the company announced it executed strategic agreements with Ormco and On Demand Orthodontist to provide Spark Clear Aligners to its national network of providers. Conduit Pharmaceuticals Inc. (NASDAQ: CDT) shares climbed 39.7% to $6.72. Histogen Inc. (NASDAQ: HSTO) gained 27% to $0.6350. Pixelworks, Inc. (NASDAQ: PXLW) gained 22% to $1.3100 after reporting preliminary revenue results for the third quarter. Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares rose 18.5% to $0.2016 after falling 15% on Tuesday. Brainstorm Cell Therapeutics recently announced the FDA Advisory Committee voted that NurOwn did not demonstrate substantial evidence of effectiveness for treatment of mild to moderate ALS. BranchOut Food Inc. (NASDAQ: BOF) gained 16% to $2.0873. BranchOut pre-announced third-quarter revenue of roughly $1.1 million. KWESST Micro Systems Inc. (NASDAQ: KWE) climbed 13% to $1.82. Air Industries Group (NYSE: AIRI) gained 13% to $3.2699. LightPath Technologies, Inc. (NASDAQ: LPTH) climbed 11.2% to $1.59. Globus Maritime Limited (NASDAQ: GLBS) shares climbed 10.1% to $0.2439. Globus Maritime regained compliance with NASDAQ's minimum closing bid price. Star Equity Holdings, Inc. (NASDAQ: STRR) gained 9.8% to $1.0105. Accuray Incorporated (NASDAQ: ARAY) climbed 9.8% to $2.85. Accuray announced approval of the Tomo C radiation treatment delivery system by the Chinese National Medical Products Administration. CalAmp Corp. (NASDAQ: CAMP) shares jumped 9.3% to $0.4490. CalAmp is expected to release its fiscal 2024 second quarter financial results on Oct. 5, 2023. FLJ Group Limited (NASDAQ:

    Benzinga
  • The company released its fiscal 2023 third-quarter numbers after the bell Wednesday.

    The Motley Fool
Page data last updated 07/25/2025 01:10:38 UTC